The two main drivers driving up the value of the oncolytic virus immunotherapy market are the rising incidence of cancer and the increase in healthcare.
The study in Nature Communications reveals that MPOX infection triggers an anti-viral antibody response akin to that from smallpox vaccination. Utilizing a comprehensive array of ELISAs, scientists found a high level of specificity and sensitivity in detecting antibodies against both MPOX and smallpox, offering a new, accurate way to measure immune responses.
Form 425 First Light Acquisition Filed by: First Light Acquisition Group, Inc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.